aNeuSTART

At-home Diagnostic Kit for Children with Autism Spectrum Disorder

Health Tech & Life Sciences
Active
Pre-Funding Rishon LeTsiyon Founded 2018
Website ↗
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
2
HQ
Rishon LeTsiyon
Sector
Health Tech & Life Sciences

About

aNeuSTART is a nutrient-based, precision-targeted, personalized action plan for children with autism spectrum disorder. Each plan is tailored to the child's unique biochemistry in order to improve their overall functioning. The company is developing a noninvasive, at-home diagnostic kit that detects which biological pathways are impacting nutritional flow to the brain, impairing its function. The company's algorithm combines the results from the diagnostic kit with the patient's health history, current symptoms, and diet. The parent receives recommendations for supplements and foods based on the child's age, symptoms, and preferences to restore proper functioning of impaired biochemical pathways. aNeuSTART's nutrient-based interventions can be started at an early age. They can also reduce behavioral symptoms and improve the quality of life of children and their families.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2CB2B

Highlights

Verified

Tags

autismdiagnosticsalgorithmspersonalizationhome-carenon-invasivenutritionrecommendationsneurologyneurosciencedigital-healthcaretargeted-therapychildren